Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan 4;22(42):6340-6352.
doi: 10.2174/1381612822666160813214023.

Cannabis Epidemiology: A Selective Review

Affiliations
Review

Cannabis Epidemiology: A Selective Review

James C Anthony et al. Curr Pharm Des. .

Abstract

Background: Globally, the most widely used set of compounds among the internationally regulated drugs is cannabis.

Objective: To review evidence from epidemiological research on cannabis, organized in relation to this field's five main rubrics: quantity, location, causes, mechanisms, and prevention/ control.

Method: The review covers a selection of evidence from standardized population surveys, official statistics, and governmental reports, as well as published articles and books identified via MEDLINE, Web of Science, and Google Scholar as of July 2016.

Results: In relation to quantity, an estimated 3% to 5% of the world population is thought to have tried a cannabis product, with at least one fairly recent use, mainly extra-medical and outside boundaries of prescribed use. Among cannabis users in the United States, roughly one in 7-8 has engaged in medical marijuana use. In relation to location, prevalence proportions reveal important variations across countries and between subgroups within countries. Regarding causes and mechanisms of starting to use cannabis, there is no compelling integrative and replicable conceptual model or theoretical formulation. Most studies of mechanisms have focused upon a 'gateway sequence' and person-to-person diffusion, with some recent work on disability-adjusted life years. A brief review of cannabis use consequences, as well as prevention and control strategies is also provided.

Conclusion: At present, we know much about the frequency and occurrence of cannabis use, with too little replicable definitive evidence with respect to the other main rubrics. Given a changing regulatory environment for cannabis products, new institutions such as an independent International Cannabis Products Safety Commission may be required to produce evidence required to weigh benefits versus costs. It is not clear that governmentsponsored research will be sufficient to meet consumer demand for balanced points of view and truly definitive evidence.

Keywords: Cannabis; epidemiology; incidence; marijuana; medical marijuana; prevalence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of and trends in official statistics about law enforcement seizures of cannabis (herb product) by country of the world. (Source: United Nations. Office of Drugs and Crime. World Drug Report 2012. United Nations Publication, https://www.unodc.org/documents/data-and-analysis/WDR2012/WDR_2012_web_small.pdf)
Figure 2
Figure 2
Estimated age of onset distributions for new initiates of cannabis use, by countries participating in the World Mental Health Surveys project. (Source: Degenhardt et al., 2008).

References

    1. Anthony J, Helzer J. Syndromes of drug abuse and dependence. In: Robins LN, Regier DA, editors. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: Free Press; 1991. pp. 116–54.
    1. Holst P. On the Statistics of the Insane, Blind, Deaf and Dumb, and Lepers, of Norway. Journal of the Statistical Society of London. 1852;15:250–6.
    1. Cheng HG, Cantave MD, Anthony JC. Taking the first full drink: Epidemiological evidence on male-female differences in the United States. Alcohol Clin Exp Res. 2016;40:816–25. - PMC - PubMed
    1. Gruenberg EM. A review of mental health in the metropolis: The Midtown Manhattan Study. Milbank Memorial Fund Quarterly. 1963;16:77–93. - PubMed
    1. Streiner DL, Patten SB, Anthony JC, Cairney J. Has ‘lifetime prevalence ‘reached the end of its life? An examination of the concept. International Journal of Methods in Psychiatric Research. 2009;18:221–8. - PMC - PubMed

Publication types

Substances